These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7581254)

  • 1. Effect of temperature in perfusate on local hepatic disposition of BOF-4272, a new xanthine oxidase inhibitor.
    Nishimura M; Yamaoka K; Yasui H; Naito S; Nakagawa T
    Biol Pharm Bull; 1995 Jul; 18(7):980-3. PubMed ID: 7581254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic local disposition of a drug with high protein binding and high hepatic clearance using BOF-4272 as a model drug.
    Nishimura M; Yamaoka K; Naito S; Nakagawa T
    Biol Pharm Bull; 1996 Sep; 19(9):1197-202. PubMed ID: 8889040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of albumin on enantioselective local disposition of BOF-4272, a xanthine oxidase inhibitor with chiral sulfoxide, in rat liver.
    Nishimura M; Yamaoka K; Naito S; Nakagawa T
    Biol Pharm Bull; 1997 Dec; 20(12):1285-9. PubMed ID: 9448105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local disposition of a new xanthine oxidase/xanthine dehydrogenase inhibitor, BOF-4272, in rat liver.
    Nishimura M; Yamaoka K; Yasui H; Naito S; Nakagawa T
    Biol Pharm Bull; 1994 Sep; 17(9):1301-4. PubMed ID: 7841959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective uptake of BOF-4272, a xanthine oxidase inhibitor with a chiral sulfoxide, by isolated rat hepatocytes.
    Naito S; Nishimura M
    Yakugaku Zasshi; 2001 Dec; 121(12):989-94. PubMed ID: 11766411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consideration on moments of outflow profile in liver perfusion system with change in perfusate flow rate using oxacillin as model drug.
    Ohata Y; Yamaoka K; Yasui H; Nakagawa T
    Biol Pharm Bull; 1996 Jan; 19(1):83-7. PubMed ID: 8820917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, after single intravenous or oral administration to male mice and rats.
    Naito S; Nishimura M; Nogawa H
    J Pharm Pharmacol; 1999 Mar; 51(3):347-51. PubMed ID: 10344637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of the xanthine oxidase inhibitor BOF-4272 and its metabolites in the liver and by the intestinal flora in rat.
    Naito S; Nishimura M
    Xenobiotica; 2000 Jan; 30(1):103-9. PubMed ID: 10659955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of protein binding effect on local disposition of oxacillin in rat liver by a two-compartment dispersion model.
    Yano Y; Yamaoka K; Minamide T; Nakagawa T; Tanaka H
    J Pharm Pharmacol; 1990 Sep; 42(9):632-6. PubMed ID: 1981901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
    Yasui H; Yamaoka K; Fukuyama T; Nakagawa T
    Drug Metab Dispos; 1995 Aug; 23(8):779-85. PubMed ID: 7493542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the pharmacological actions and pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, in mouse liver.
    Naito S; Nishimura M; Tamao Y
    J Pharm Pharmacol; 2000 Feb; 52(2):173-9. PubMed ID: 10714947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic properties of a novel xanthine oxidase inhibitor, BOF-4272, in healthy volunteers.
    Uematsu T; Nakashima M
    J Pharmacol Exp Ther; 1994 Aug; 270(2):453-9. PubMed ID: 8071837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of perfusion rate on the local disposition of cefixime in liver perfusion system based on two-compartment dispersion model.
    Yano Y; Yamaoka K; Yasui H; Nakagawa T
    Drug Metab Dispos; 1991; 19(6):1022-7. PubMed ID: 1687006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the enantioselective binding between BOF-4272 and serum albumins by means of high-performance frontal analysis.
    Shibukawa A; Kadohara M; He JY; Nishimura M; Naito S; Nakagawa T
    J Chromatogr A; 1995 Mar; 694(1):81-9. PubMed ID: 7719472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthine oxidase inhibition attenuates kupffer cell production of neutrophil chemoattractant following ischemia-reperfusion in rat liver.
    Matsumura F; Yamaguchi Y; Goto M; Ichiguchi O; Akizuki E; Matsuda T; Okabe K; Liang J; Ohshiro H; Iwamoto T; Yamada S; Mori K; Ogawa M
    Hepatology; 1998 Dec; 28(6):1578-87. PubMed ID: 9828222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic pathways and pharmacokinetics of BOF-4272, a sulfoxide-containing drug, in the dog: in vivo and in vitro studies.
    Naito S; Nishimura M; Yoshitsugu H; Nogawa H
    Biol Pharm Bull; 1999 Dec; 22(12):1391-5. PubMed ID: 10746178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition of xanthine oxidase with a new tight binding inhibitor.
    Okamoto K; Nishino T
    J Biol Chem; 1995 Apr; 270(14):7816-21. PubMed ID: 7713871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moment analysis of stereoselective biliary excretion and chiral inversion of ketoprofen enantiomers in perfused rat liver.
    Yasui H; Yamaoka K; Dote N; Nakagawa T
    J Pharm Sci; 1995 Nov; 84(11):1327-31. PubMed ID: 8587051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic disposition characteristics of 111In-labeled lactosaminated bovine serum albumin in rats.
    Nishida K; Eguchi Y; Takino T; Takakura Y; Hashida M; Sezaki H
    Pharm Res; 1991 Oct; 8(10):1253-7. PubMed ID: 1796043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies on the stereoselective pharmacokinetics and biotransformation of an (S)-(-)- and (R)-(+)-pyrazolotriazine sulfoxide in the male rat.
    Naito S; Nishimura M
    Xenobiotica; 2002 Jun; 32(6):491-503. PubMed ID: 12160482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.